- 1. (DMSO)
- [highly polar organic liquid, that is used widely as a chemical solvent; because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals; it is also used to protect tissue during cryopreservation; dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation. ( CSP )] (UMLS (NCI) C0012403) =Organic Chemical; Pharmacologic Substance ;
=Sulfoxides;
sulfoxide;
Inactive Ingredient Preparations;
=DIMETHYL SULFOXIDE 50 %;
DIMETHYL SULFOXIDE 100 %;
| - 10. DMI WO CMP NT ST UNCNTRL
- [ ] (UMLS (ICD9CM) C0375114) =Disease or Syndrome
|
- 2. D-Mannitol
- [six-carbon sugar alcohol formed by reduction of mannose or fructose and widely distributed in plants and fungi. ( CSP )] (UMLS (NCI) C0024730) =Carbohydrate; Pharmacologic Substance ;
=sugar alcohol;
sweetening agent;
[IR100] IRRIGATION SOLUTIONS;
[CV709] DIURETICS, OTHER =MANNITOL HEXANITRATE;
AL OH 400MG/MG OH 400MG/SIMETHICONE 30MG TAB,CHEWABLE;
Aluminum Hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet;
Ascorbic Acid 300 MG / Ferrous fumarate 134 MG Chewable Tablet;
CAFFEINE 100 MG Oral (systemic) tablet;
Doxycycline 10 MG/ML Injectable Solution;
Menthol 0.0012 MG/MG / phenol 0.0072 MG/MG Lozenge;
Menthol 0.0012 MG/MG / phenol 0.0145 MG/MG Lozenge;
ULTRA-KLENZ,WOUND CLEANSER;
MANNITOL 100 MG/ML;
MANNITOL 150 MG/ML;
MANNITOL 200 MG/ML;
MANNITOL 250 MG/ML;
MANNITOL 0.54 GM/100ML;
MANNITOL 50 MG/ML;
MANNITOL 375 MG;
MANNITOL 400 MG;
MANNITOL 50 MG;
MANNITOL 10 MG;
MANNITOL 10 MG/ML;
MANNITOL 100 MG;
MANNITOL 200 MG;
MANNITOL 40;
MANNITOL 40 MG;
MANNITOL 5 %;
MANNITOL 5 MG;
MANNITOL 500 MG;
MANNITOL 61.3 MG/ML;
MANNITOL 75 MG;
MANNITOL 750 MG;
MANNITOL 80 MG;
MANNITOL 150 MG;
MANNITOL 1.5 GM/VIL | - 11. DMI WO CMP UNCNTRLD
- [ ] (UMLS (ICD9CM) C0375116) =Disease or Syndrome
|
- 3. D1/3 MAGE3 HIS
- [A recombinant, chimeric protein derived from a melanoma antigenic epitope (MAGE-3) and recognized by specific cytotoxic T lymphocytes. MAGE-3, a human peptide epitope present in the cytosol of melanoma cells, may be expressed as the fusion protein D1/3-Mage-3; this fusion protein may boost antitumoral immune responses when used in a vaccine formulation. (NCI04) ( NCI )] (UMLS (NCI) C1327743) D1/3-MAGE-3 Fusion Protein;
D1/3-Mage-3-His Fusion Protein;
D1/3-Mage-3-His Fusion Protein (SB MAGE-3) =Amino Acid, Peptide, or Protein; Pharmacologic Substance | - 12. DMII KETO NT ST UNCNTRLD
- [ ] (UMLS (ICD9CM) C0375117) =Disease or Syndrome
|
- 4. DM
- [An island between the Caribbean Sea and the North Atlantic Ocean, about one-half of the way from Puerto Rico to Trinidad and Tobago. (NCI) ( NCI )] (UMLS (NCI) C0013013) =Geographic Area
| - 13. DMII KETOACD UNCONTROLD
- [ ] (UMLS (ICD9CM) C0375119) =Disease or Syndrome
|
- 5. DMDT
- [An insecticide. Methoxychlor has estrogenic effects in mammals, among other effects. ( MSH )] (UMLS (CSP) C0025685) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 14. DMII WO CMP NT ST UNCNTR
- [ ] (UMLS (ICD9CM) C0375113) =Disease or Syndrome
|
- 6. DMDT (dimethoxydiphenyltrichloroethane)
- [ ] (UMLS (CSP) C0598156) =Organic Chemical; Hazardous or Poisonous Substance
| - 15. DMII WO CMP UNCNTRLD
- [ ] (UMLS (ICD9CM) C0375115) =Disease or Syndrome
|
- 7. DMF
- (UMLS (NCI) C0060056) =Therapeutic or Preventive Procedure ;
| - 16. DMP 266
- [ ] (UMLS (CSP) C0387216) =Organic Chemical; Pharmacologic Substance ;
|
- 8. DMI KETO NT ST UNCNTRLD
- [ ] (UMLS (ICD9CM) C0375118) =Disease or Syndrome
| - 17. DMP 777
- [ ] (UMLS (CSP) C0539069) =Organic Chemical; Pharmacologic Substance
|
- 9. DMI KETOACD UNCONTROLD
- [ ] (UMLS (ICD9CM) C0375120) =Disease or Syndrome
| |
home 
Armenian-English 
top